Systemic Vasculitis clinical trials
The registry lists 61 studies for Systemic Vasculitis across more than 10 countries. 11 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-08.
Status
- Completed
- 27
- Status unknown
- 11
- Recruiting
- 7
- Terminated
- 7
- Not yet recruiting
- 3
- Active, not recruiting
- 3
Phase
- Phase 2
- 13
- Phase 3
- 11
- Phase 4
- 9
- Phase 1
- 2
Where
- United States
- 28
- United Kingdom
- 15
- Canada
- 12
- France
- 12
- Germany
- 8
- Japan
- 7
Who runs them
University of Pennsylvania (5) · Assistance Publique - Hôpitaux de Paris (5) · Cambridge University Hospitals NHS Foundation Trust (4) · University of South Florida (4) · GlaxoSmithKline (3) · Medical University of Warsaw (2) · National Jewish Health (2) · Johns Hopkins University (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 61 — search for more.
- Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Cases of ANCA Reappearance in Granulomatosis With Polyangiitis and Microscopic Polyangiitis.Not yet recruitingNCT07451847Phase 41 country
- Vasculitis Pregnancy RegistryRecruitingNCT025935651 country
- Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy ControlsRecruitingNCT072760871 country
- Circulating B-cell, Drug and Anti-drug Antibodies Monitoring in Patients Treated With Rituximab for Autoimmune DisordersRecruitingNCT070377321 country
- Special Drug Use-results Survey for Long-term Use（Avacopan）RecruitingNCT067582711 country
- Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune DiseasesEnrolling by invitationNCT05859997Not applicable1 country
- Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)RecruitingNCT06350110Phase 1/21 country
- Rare AutoImmune SElf-management Programme DevelopmentRecruitingNCT066428701 country
- The Epigenomic Signature of Eosinophilic Granulomatosis With PolyangiitisNot yet recruitingNCT06231498
- Clonal Hematopoiesis in Giant Cell ArteritisNot yet recruitingNCT06244069
- Pediatric Vasculitis InitiativeRecruitingNCT020061347 countries
- Acquired Immunodeficiency in ANCA Associated VasculitisCompletedNCT03514979Phase 21 country
- Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic DiseasesActive, not recruitingNCT05879419Phase 41 country
- Cardiovascular Status of Children 5 Years After Kawasaki DiseaseCompletedNCT037501231 country
- Evaluation of Platelet Aggregability in Patients with Takayasu's ArteritisActive, not recruitingNCT068077881 country
- Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in JapanCompletedNCT045519891 country
- The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric ApproachActive, not recruitingNCT01933724Phase 31 country
- Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)CompletedNCT02108860Phase 35 countries
- Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia.CompletedNCT057038021 country
- Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921CompletedNCT03298061Phase 37 countries
- Eosinophilic Granulomatosis With Polyangiitis CohortCompletedNCT030366701 country
- Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic DiseaseCompletedNCT03762824Phase 4
- PRagmatic Analysis of Vitamin D in ANCA-Associated VasculitisCompletedNCT04280601Not applicable1 country
- COvid-19 Vaccine Booster in Immunocompromised Rheumatic DiseasesStatus unknownNCT05236491Phase 2/31 country
- Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.CompletedNCT03895801Phase 211 countries
- Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic PolyangiitisCompletedNCT003153932 countries
- Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPATerminatedNCT03712345Phase 22 countries
- Rituximab Vasculitis Maintenance StudyCompletedNCT01697267Phase 310 countries
- Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPAStatus unknownNCT04944524Phase 41 country
- Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated VasculitisCompletedNCT02169219Phase 41 country
- Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) StudyStatus unknownNCT03010436Phase 21 country
- Natural History of Granulomatosis With Polyangiitis: Clinical and Genetic Biomarkers of Airway Disease NoAAC PR-03 StudyWithdrawnNCT031820491 country
- Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated VasculitisCompletedNCT00987389Phase 315 countries
- A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic PolyangiitisCompletedNCT01750697Phase 28 countries
- Resistance Exercise in Rheumatic DiseaseTerminatedNCT01599260Not applicable1 country
- Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia VasculitisTerminatedNCT02556866Phase 21 country
- Cardiovascular Involvement in Patients With Granulomatosis With PolyangiitisStatus unknownNCT037828701 country
- An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic PolyangiitisCompletedNCT016135991 country
- Study of Refractory and/or Relapsing TAkayasu aRTeritisStatus unknownNCT035435271 country
- Journey of Patients With Vasculitis From First Symptom to DiagnosisCompletedNCT034102901 country
- Rituximab for the Otolaryngologic Manifestations of Granulomatosis With PolyangiitisTerminatedNCT02626845Phase 41 country
- A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With PolyangiitisCompletedNCT02020889Phase 39 countries
- Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up StudyTerminatedNCT015868582 countries
- Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) StudyStatus unknownNCT02947945Phase 21 country
- GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic DiseasesTerminatedNCT01257802Phase 31 country
- The ANCA Vasculitis Questionnaire (AAV-PRO©)CompletedNCT025070241 country
- Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic PolyangiitisCompletedNCT00104299Phase 2/32 countries
- American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic VasculitisStatus unknownNCT0106620833 countries
- Magnetic Resonance Angiography vs Ultrasonography in Systemic Large vEssel vasculitiSCompletedNCT02042092Not applicable1 country
- Impact of Vasculitis on Employment and IncomeCompletedNCT024762921 country